Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT.

Clinical and translational radiation oncology·2026
Same author

Raman spectroscopy with machine-learning classification for the prediction of stereotactic radiotherapy induced treatment toxicity in high-risk localised prostate cancer.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

An evaluation of rectum contours generated by artificial intelligence automatic contouring software using geometry, dosimetry and predicted toxicity.

Biomedical physics & engineering express·2025
Same author

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.

The Lancet. Oncology·2025
Same author

Implantable Rectal Spacers in Prostate Cancer Radiation Therapy: A Systematic Review.

Practical radiation oncology·2025
Same author

Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial.

BMJ open·2024

相关实验视频

Updated: May 11, 2026

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.3K

针对过量采样的生物评估框架 (BEFO) 基因表达数据.

Kevin Fee1, Suneil Jain2, Ross G Murphy3

  • 1Queen's University Belfast School of Electronics, Electrical Engineering and Computer Science, 16A Malone Rd, Belfast, BT9 5BN, Ulster, Northern Ireland, UK.

Journal of biomedical informatics
|October 19, 2025
PubMed
概括

本研究引入了过量采样生物评估框架 (BEFO),以改进生物医学研究中的机器学习模型. BEFO确保合成数据反映生物模式,提高模型准确性和临床应用的可靠性.

关键词:
生物可行性 生物可行性临床可靠性 临床可靠性基因的共同表达.随机森林是随机的森林.样本的重要性 样本的重要性综合数据 综合数据

更多相关视频

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.7K
Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes
05:07

Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes

Published on: November 7, 2025

340

相关实验视频

Last Updated: May 11, 2026

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.3K
Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.7K
Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes
05:07

Rup (RNA-seq Usability Assessment Pipeline) - Quality Control for Bulk RNA-seq Experiments in Eukaryotes

Published on: November 7, 2025

340

科学领域:

  • 生物医学研究的研究.
  • 机器学习应用程序 机器学习应用程序
  • 数据科学是数据科学.

背景情况:

  • 机器学习 (ML) 模型越来越多地用于生物医学研究,以改善诊断和预后.
  • 生物医学数据集经常表现出类不平衡,导致有偏见的ML模型.
  • 现有的过量采样技术缺乏合成数据的生物验证,限制了临床适用性.

研究的目的:

  • 引入过量采样生物评估框架 (BEFO),以确保合成基因表达数据准确地反映生物模式.
  • 为了减轻ML模型中的偏差,并提高临床环境中预测的可靠性.
  • 建立一个新的标准,用于评估合成数据在生物医学ML.

主要方法:

  • 开发了一种基于权重基因共同表达网络分析 (WGCNA) 基因共同表达集群的合成样本的排名方法.
  • 构建随机森林以评估合成样本与生物集群的对齐.
  • 仅包括比真实样本更重要的合成样本.

主要成果:

  • 根据BEFO框架,过量采样数据集的生物可行性平均提高了11%.
  • 与最先进的方法相比,分类性能平均提高了9%.
  • 在六个真实世界的基因表达数据集中使用十个分类算法进行评估.

结论:

  • 拟议的ML过量采样框架提高了生物相关性和预测性能.
  • BEFO提供了一种可靠的方法来验证生物医学ML中的合成数据.
  • 这种方法提高了ML决策支持系统在临床实践中的可靠性.